MedTrace Logo

A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer

NCT03707444 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-11-29

No results posted yet for this study

Summary

Pain is the predominant and most feared symptom of pancreas cancer, and is often incompletely relieved. Scrambler Therapy is a new way of treating pain by providing "non-pain" information to confuse the nervous system and reset the damaged nerve pathways. It has been useful in treating many types of pain, but has not been adequately tested in the pain associated with pancreas cancer. The goal of this study is to evaluate the effect of Scrambler Therapy on typical abdominal pain associated with pancreas cancer. The investigators hypothesize that pain scores from day 0 (pre) to day 28 (post) will be reduced by at least 33%, e.g. from 6/10 to 4/10.

Conditions

  • Cancer Pancreas
  • Pain Syndrome
  • Cancer Related Pain

Interventions

DEVICE

Scrambler Therapy Device

Superficial neuromodulation using EKG type electrodes \[Scrambler (MC5-A Calmare) Therapy\]

Sponsors & Collaborators

  • Ho-Chiang Foundation

    collaborator UNKNOWN

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Thomas J Smith, MD · Johns Hopkins Sidney Kimmel COmprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-10-31
Completion
2019-11-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03707444 on ClinicalTrials.gov